Human immunodeficiency virus (HIV) infection

Annals of Internal Medicine

Volumn 120, Issue 4, 1994, Pages 310-319

  Eickhoff, Theodore C ^b   White, Linda Johnson ^a  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY DETECTION; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEDICAL ETHICS; PATIENT RIGHT; PRIORITY JOURNAL; PROFESSIONAL SECRECY; REVIEW; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

EID: 23444449869     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-120-4-199402150-00009     Document Type: Review

References (74)

1. Health and Public Policy Committee, American College of Physicians; and the Infectious Diseases Society of America. Acquired immunodeficiency syndrome. Ann Intern Med. 1986;104:575-81.
2. Health and Public Policy Committee, American College of Physicians; and the Infectious Diseases Society of America. The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV). Ann Intern Med. 1988;108:460-9.
3. HIV/AIDS surveillance. U.S. AIDS cases reported through June, 1991. Atlanta, Georgia: Centers for Disease Control; July 1991.
4. HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop. MMWR Morb Mortal Wkly Rep. 1990;39(RR-16):1-31.
5. The second 100,000 cases of acquired immunodeficiency syndrome - United States, June 1981-December 1991. MMWR Morb Mortal Wkly Rep. 1992;41:28-9.
6. CHIV/AIDS Surveillance Year-End Edition. Atlanta, Georgia: Centers for Disease Control and Prevention; February 1993.
7. Update: mortality attributable to HIV infection/AIDS among persons aged 25-44 years - United States, 1990 and 1991. MMWR Morb Mortal Wkly Rep. 1993;42:481-6.
8. Mann JM. AIDS - the second decade: a global perspective. J Infect Dis. 1992;165:245-50.
9. Chaisson RE, Volberding PA. Clinical manifestations of HIV infection. In: Mandell GL, Douglas RG, Bennett JE; eds. Principles and Practice of Infectious Diseases. 3d ed. New York: Churchill Livingstone; 1990:1059-92.
10. Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1991;114:678-93.
11. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1989;239:617-22.
12. Volberding PV, Lagakos SW, Koch MA, Petinelli C, Myers MW Booth DK, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med. 1990; 322:941-9.
13. Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, et al. The safety and efficacy of zidovudine in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann Intern Med. 1990;112:727-37.
14. Hellinger FJ. Updated forecasts of the costs of medical care for persons with AIDS. Public Health Rep. 1990;105:1-12.
15. Bartlett JA. Chronic management and counseling for persons with HIV infection. In: Wyngaarden JB, Smith LH, Bennett JC; eds Cecil Textbook of Medicine. 19th ed. Philadelphia: W.B. Saunders; 1992:1965-70.
16. Sattler FR. Pulmonary manifestations of AIDS: special emphasis on pneumocystosis. In: Wyngaarden JB, Smith LH, Bennett JC; eds. Cecil Textbook of Medicine. 19th ed. Philadelphia: W.B. Saunders; 1992:1932-42.
17. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991:324:1644-50.
18. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991;40:585-91.
19. Hellinger FJ. Forecasting the medical care costs of the HIV epidemic: 1991-1994. Inquiry. 1991;28:213-25.
20. Sloand EM, Pitt E, Chiarello RJ, Nemo GJ. HIV testing. State of the art. JAMA. 1991;266:2861-6.
21. Fauci AS, Gallo RC, Koenig S, Salk J, Purcell RH. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;110:373-85.
22. Redfield RR, Birx DL, Ketter N, Tramont E, Polonis V, Davis C, et al. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. N Engl J Med. 1991:324:1677-84.
23. Fauci AS. Optimal immunity to HIV - natural infection, vaccination, or both? N Engl J Med. 1991:324;24;1733-5.
24. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
25. Possible transmission of human immunodeficiency virus to a patient during an invasive dental procedure. MMWR Morb Mortal Wkly Rep. 1990;39:489-93.
26. Update: transmission of HIV infection during an invasive dental procedure - Florida. MMWR Morb Mortal Wkly Rep. 1991;40:21-33.
27. Update: transmission of HIV infection during invasive dental procedures - Florida. MMWR Morb Mortal Wkly Rep. 1991;40:377-81.
28. Mishu B, Schaffner W, Horan JM, Wood LH, Hutcheson RH, Mc-Nabb PC. A surgeon with AIDS. Lack of evidence of transmission to patients. JAMA. 1990:264:467-70. [Erratum. JAMA. 1990;264: 1661.]
29. Armstrong FP, Miner JC, Wolfe WH. Investigation of a health care worker with symptomatic human immunodeficiency virus infection: an epidemiologic approach. Mil Med. 1987;152:414-8.
30. Porter JD, Cruickshank JG, Gentle PH, Robinson RG, Gill ON. Management of patients treated by surgeon with HIV infection [Letter]. Lancet. 1990;335:113-4.
31. Danila RN, MacDonald KL, Rhame FS, Moen ME, Reier DO, Le-Tourneau JC, et al. A look-back investigation of patients of an HIV-infected physician. Public health implications. N Engl J Med. 1991;325:1406-11.
32. Dickinson GD, Morhart RE, Klimas NG, Bandea CI, Laracuente JM, Bisno AL. Absence of HIV transmission from an infected dentist to his patients. JAMA. 1993;269:1802-6.
33. Rogers AS, Froggatt JW 3d, Townsend T, Gordon T, Brown AJ, Holmes EC, et al. Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA. 1993;269:1795-801.
34. von Reyn CF, Gilbert TT, Shaw FE Jr, Personnet KC, Abramson JE, Smith MG. Absence of HIV transmission from an infected orthopedic surgeon. JAMA. 1993;269;1807-11.
35. Rosser SV. AIDS and women. AIDS Educ Prev. 1991;3:230-40.
36. Somerville MA, Orkin AJ. Human rights, discrimination and AIDS: concepts and issues. AIDS 1989;3:(Suppl 1)S283-7.
37. Stein MD, Piette J, Mor V, Wachtel TJ, Fleishman J, Mayer KH, Carpenter CC. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med. 1991;6:35-40.
38. Green J, Arno PS. The "Medicaidization" of AIDS. Trends in the financing of HIV-related medical care. JAMA. 1990;264:1261-6.
39. American College of Physicians Ethics Committee. Ethics Manual. 3d ed. Ann Intern Med. 1992;117:947-60.
40. Clarke OW, Conley RB. The duty to "attend upon the sick." JAMA. 1991;266:2876-7.
41. Gerbert B, Maguire BT, Bleecker T, Coates TJ, McPhee SJ. Primary care physicians and AIDS. Attitudinal and structural barriers to care. JAMA. 1991;266:2837-42.
42. Ness RB, Kelly JV, Kilian CD. House staff recruitment to municipal and voluntary New York City residency programs during the AIDS epidemic. JAMA. 1991:266:2843-6.
43. Hayward RA, Shapiro MF. A national study of AIDS and residency training: experiences, concerns, and consequences. Ann Intern Med. 1991;114:23-32.
44. Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S, et al. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med. 1991;325:1-5.
45. Bayer R. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? N Engl J Med. 1991;324:1500-4.
46. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep. 1987;36:509-15.
47. Marcus R. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N Engl J Med. 1988;319:1118-23.
48. Gerberding JL, Bryant-LeBlanc CE, Nelson K, Moss AR, Osmond D, Chambers HF, et al. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis. 1987;156:1-8.
49. Henderson DK, Fahey BJ, Willy M, Schmitt JM, Carey K. Koziol DE, et al. The risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med. 1990;113:740-6.
50. Bell DM. Basis for considering certain procedures exposure-prone. Proceedings of the open meeting to discuss invasive procedures under consideration for designation as exposure-prone and not exposure-prone. Centers for Disease Control, Atlanta, Georgia. 14 November 1991.
51. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Morb Mortal Wkly Rep. 1991; 40:1-9.
52. U.S. Congress House off Representatives. Making appropriations for the Treasury Department, the US Postal Service, the Executive Office of the President, and certain independent agencies, for the fiscal year ending September 30, 1992, and for other purposes. Washington, DC: House of Representatives; 1991. Conference Report 102-35.
53. Centers for Disease Control. Proceedings of the open meeting on the risks of transmission of bloodborne pathogens to patients during invasive procedures. Atlanta, Georgia. 21-22 February 1991.
54. Centers for Disease Control. Proceedings of the open meeting to discuss invasive procedures under consideration for designation as exposure-prone and not exposure-prone. Atlanta, Georgia. 14 November 1991.
55. Frandzel S. Organizations defend their positions at CDC conference on HIV-infected health care workers. AIDS Patient Care. 1991;5: 129-32.
56. Knopp RK, Adams J, Derse A, Franaszek J, Green C, Isersun K, et al. The HIV-infected emergency health care professional. Ann Emerg Med. 1991;20:1036-40.
57. Statement of the American College of Physicians before the Centers for Disease Control. Philadelphia: American College of Physicians; 1991.
58. The Surgeon and HIV Infection: A Statement. Chicago: American College of Surgeons; 1991.
59. Ad Hoc Committee on HIV-infected Health Care Workers. Michigan recommendations on HIV-infected health care workers. Lansing, Michigan: Michigan Department of Public Health; 1991.
60. Policy Statement and Guidelines: Health Care Facilities and HIV-infected Medical Personnel. Albany, New York: Office of Public Health, New York State Department of Health; 1991.
61. Policy Statement and Action Plan To Prevent Transmission of HIV through Medical/Dental Procedures. Albany, New York: Office of Public Health, New York State Department of Health; 1991.
62. Bell DM. Estimates of the risk of endemic transmission of hepatitis B virus and human immunodeficiency virus to patients by the percutaneous route during invasive surgical and dental procedures. Proceedings of the open meeting on the risks of transmission of bloodborne pathogens to patients during invasive procedures. Centers for Disease Control, Atlanta, Georgia. 21-22 February 1991.
63. McArthur JC, Cohen BA, Selnes OA, Kumar AJ, Cooper K, McArthur JH, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the Multicenter AIDS Cohort Study. Ann Neurol. 1989;26:601-11.
64. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology. 1989;39:119-22.
65. Seines OA, Miller E, McArthur J, Gordon B, Munoz A, Sheridan K, et al. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study. Neurology. 1990;40:204-8.
66. Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, et al. Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology. 1990;40:197-203.
67. Gerberding JL. Expected costs of implementing a mandatory human immunodeficiency virus and hepatitis B virus testing and restriction program for healthcare workers performing invasive procedures. Infect Control Hosp Epidemiol. 1991;12:443-7.
68. Friedland GH, Saltzman BR, Rogers MF, Kahl PA, Lesser ML, Mayers MH, Klein RS. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med. 1986;314: 344-9.
69. Steinbrook R, Lo B, Tirpack J, Dilley JW, Volberding PA. Ethical dilemmas in caring for patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1985;103:787-90.
70. Kanoti GA. The ethical implications of AIDS. In: Blanchet KD; ed. AIDS: A Health Care Management Response. Rockville, Maryland: Aspen Publishers; 1988:81-98.
71. Gemson DH, Colombotos J, Elinson J, Fordyce EJ, Hynes M, Stoneburner R. Acquired immunodeficiency syndrome prevention. Knowledge, attitudes, and practices of primary care physicians. Arch Intern Med. 1991;151:1102-8.
72. Koop CE. Physician leadership in preventing AIDS [Editorial]. JAMA. 1987;258:2111.
73. Fitzgibbon JE, Gaur S, Frankel LD, Laraque F, Edlin B, Dubin DT. Transmision from one child to another of human immunodeficiency virus type 1 with a zidovudine resistance mutation. N Engl J Med. 1993;329:2835-41.
74. Simons RJ, Rogers MF. HIV prevention: bringing the message home. N Engl J Med. 1993;329:1883-5.